Rusnano

FlexEnable raises $11-$25M to take flexible displays and active optics to mass production

Retrieved on: 
Tuesday, February 22, 2022
OEM, LC, AR, FPD, Television, Novar plc, Industry, VR, Electronics, Tablet, Tier 1, FlexEnable, LCD, IP, Engineering, Technology, Technology transfer, Light, Solution, CEO, Coretronic, Rusnano

The initial $11M investment includes options for a further $14m and is expected to finance FlexEnable through to mass production ramp up of flexible displays and liquid crystal optical modules at Asian display manufacturing partners.

Key Points: 
  • The initial $11M investment includes options for a further $14m and is expected to finance FlexEnable through to mass production ramp up of flexible displays and liquid crystal optical modules at Asian display manufacturing partners.
  • The funds will also be used to scale up the company's organic materials production capacity to meet the growing needs of display manufacturing partners entering volume production.
  • As a principal player in the LCD supply chain, Coretronic's deep industry expertise will be a great benefit to us as we now move from production setup to mass production.
  • Applications for FlexEnable's technology include flexible displays and flexible active optical films for consumer electronics, AR/VR and automotive applications.

Sistema PJSFC:  Sistema launches start-up fund Sistema SmartTech

Retrieved on: 
Thursday, February 27, 2020
Rusnano, Science and technology in Russia, Sistema, Economy of Russia, Companies

Moscow, 27 February 2020 - Sistema PJSFC ("Sistema" or "the Corporation") (LSE: SSA, MOEX: AFKS), a Russian publicly-traded diversified holding company, announces the launch of SistemaSmartTech ("Sistema SmartTech" or "the Fund"), a fund aimed at supporting early-stage and start-up companies from seed investment to Series A funding.

Key Points: 
  • Moscow, 27 February 2020 - Sistema PJSFC ("Sistema" or "the Corporation") (LSE: SSA, MOEX: AFKS), a Russian publicly-traded diversified holding company, announces the launch of SistemaSmartTech ("Sistema SmartTech" or "the Fund"), a fund aimed at supporting early-stage and start-up companies from seed investment to Series A funding.
  • In addition to Sistema, which shall act as an anchor investor, the Fund will also include third-party investors, a number of whom have already expressed an interest in participation.
  • Sistema SmartTech will have a total lifespan of eight years, with an investment period of five years.
  • Sistema SmartTech will join Sistema's family of funds, which also includes Sistema Venture Capital (investments in growth-stage high-tech companies), Sistema Asia Fund (investments in high-tech companies in India and Southeast Asia) and Rusnano Sistema SICAR (a joint fund of Sistema and Rusnano established in 2016 for investments in growth-stage tech companies with a focus on Smart City projects).

GLOBAL QUARTZ MARKET FORECAST 2019-2027

Retrieved on: 
Monday, October 28, 2019
Physical sciences, Chemistry, Natural sciences, Heraeus, Nihon Dempa Kogyo, Electronic oscillators, Rusnano, Quartz, Crystal oscillator, Photovoltaics, Nordic Mining, Silicon

The global quartz market is projected to record progress, with a CAGR of 4.81% during the forecast period.

Key Points: 
  • The global quartz market is projected to record progress, with a CAGR of 4.81% during the forecast period.
  • The bioactive glass market is undergoing rapid growth, for which quartz is used as a raw material.It is also used as a raw material in silicon metals that are used in photovoltaic solar cells.
  • The global quartz market is segregated and studied on the basis of regional markets of North America, Europe, Asia Pacific, and the Rest of the World.
  • The global market has the presence of many players contributing to the market growth.Nordic Mining ASA, Heraeus Holding GmbH, Jiangsu Pacific Quartz Co.
    Ltd., Rusnano Group, Momentive Performance Materials, Nihon Dempa Kogyo Co., Ltd., etc.

Global Cancer Technology Appoints UC San Diego Moores Cancer Center Researcher, Dr. Milan Makale, as Chief Technology Officer

Retrieved on: 
Monday, October 14, 2019
Oncology, Health, Technology, Nanotechnology, Pharmaceutical, Biotechnology, UC San Diego Health, Moores Cancer Center, Rusnano, Economy of Russia

, Radiosurgery Neurosurgeon, Private Practice; and, Wolf Wrasidlo, Ph.D. , UC San Diego Moores Cancer Center.

Key Points: 
  • , Radiosurgery Neurosurgeon, Private Practice; and, Wolf Wrasidlo, Ph.D. , UC San Diego Moores Cancer Center.
  • Dr. Makale is Assistant Adjunct Professor of Radiation Medicine and Applied Science at UC San Diego Moores Cancer Center.
  • Dr. Makale is a co-founder of Global Cancer Technology; a co-founder of MCW Pharmaceuticals; and an adviser to RusNano, Chinese Pharma, Trogenex, and Imagion.
  • San Diego-based Global Cancer Technology is an emerging medical technology company with a robust pipeline focused on fighting cancer.